<VariationArchive VariationID="285669" VariationName="NM_213599.3(ANO5):c.2004del (p.Leu669fs)" VariationType="Deletion" Accession="VCV000285669" Version="17" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-07" DateCreated="2017-12-19" MostRecentSubmission="2024-07-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="269906" VariationID="285669">
      <GeneList>
        <Gene Symbol="ANO5" FullName="anoctamin 5" GeneID="203859" HGNC_ID="HGNC:27337" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22192473" stop="22283357" display_start="22192473" display_stop="22283357" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22214721" stop="22304912" display_start="22214721" display_stop="22304912" Strand="+" />
          </Location>
          <OMIM>608662</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_213599.3(ANO5):c.2004del (p.Leu669fs)</Name>
      <CanonicalSPDI>NC_000011.10:22270414:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="22270415" stop="22270415" display_start="22270415" display_stop="22270415" variantLength="1" positionVCF="22270414" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="22291961" stop="22291961" display_start="22291961" display_stop="22291961" variantLength="1" positionVCF="22291960" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L668fs</ProteinChange>
      <ProteinChange>L669fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.22270417del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.22270417del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.22291963del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.22291963del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015844.1" sequenceAccession="NG_015844" sequenceVersion="1" change="g.82242del">
            <Expression>NG_015844.1:g.82242del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142649.2" sequenceAccession="NM_001142649" sequenceVersion="2" change="c.2001del">
            <Expression>NM_001142649.2:c.2001del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001136121.1" sequenceAccession="NP_001136121" sequenceVersion="1" change="p.Leu668fs">
            <Expression>NP_001136121.1:p.Leu668fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.2004del" MANESelect="true">
            <Expression>NM_213599.3:c.2004del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_998764.1" sequenceAccession="NP_998764" sequenceVersion="1" change="p.Leu669fs">
            <Expression>NP_998764.1:p.Leu669fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_868" sequenceAccession="LRG_868">
            <Expression>LRG_868:g.82242del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.2" sequenceAccession="NM_213599" sequenceVersion="2" change="c.2004delG">
            <Expression>NM_213599.2:c.2004delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_868t1" sequenceAccession="LRG_868t1">
            <Expression>LRG_868t1:c.2004del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_213599.3" sequenceAccession="NM_213599" sequenceVersion="3" change="c.2004delG" MANESelect="true">
            <Expression>NM_213599.3:c.2004delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10605199" DB="ClinGen" />
        <XRef Type="rs" ID="886043172" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_213599.3(ANO5):c.2004del (p.Leu669fs) AND not provided" Accession="RCV000523626" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-02-05" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.2004del (p.Leu669fs) AND multiple conditions" Accession="RCV000700782" Version="4">
        <ClassifiedConditionList TraitSetID="39863">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.2004del (p.Leu669fs) AND Miyoshi muscular dystrophy 3" Accession="RCV001333777" Version="1">
        <ClassifiedConditionList TraitSetID="554">
          <ClassifiedCondition DB="MedGen" ID="C2750076">Miyoshi muscular dystrophy 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.2004del (p.Leu669fs) AND multiple conditions" Accession="RCV003483604" Version="1">
        <ClassifiedConditionList TraitSetID="9870">
          <ClassifiedCondition DB="MedGen" ID="C1969785">Autosomal recessive limb-girdle muscular dystrophy type 2L</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1833736">Gnathodiaphyseal dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2750076">Miyoshi muscular dystrophy 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_213599.3(ANO5):c.2004del (p.Leu669fs) AND Autosomal recessive limb-girdle muscular dystrophy" Accession="RCV004525917" Version="2">
        <ClassifiedConditionList TraitSetID="12373">
          <ClassifiedCondition DB="MedGen" ID="C2931907">Autosomal recessive limb-girdle muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-01" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2017-12-19" MostRecentSubmission="2024-07-07">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21186264</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23606453</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23663589</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25891276</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30919934</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ANO5</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="554" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6803" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 3</ElementValue>
                <XRef ID="Miyoshi+muscular+dystrophy+3/8905" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013222" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Miyoshi myopathy 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD3</ElementValue>
                <XRef Type="MIM" ID="613319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17653" />
                <XRef ID="17653" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="399096" DB="Orphanet" />
              <XRef ID="C2750076" DB="MedGen" />
              <XRef ID="MONDO:0013222" DB="MONDO" />
              <XRef Type="MIM" ID="613319" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12373" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0015152" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19825" />
                <XRef ID="19825" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="102015" DB="Orphanet" />
              <XRef ID="C2931907" DB="MedGen" />
              <XRef ID="MONDO:0015152" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS253600" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9870" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
            <Trait ID="6803" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Miyoshi muscular dystrophy 3</ElementValue>
                <XRef ID="Miyoshi+muscular+dystrophy+3/8905" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013222" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Miyoshi myopathy 3</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MMD3</ElementValue>
                <XRef Type="MIM" ID="613319" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17653" />
                <XRef ID="17653" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="399096" DB="Orphanet" />
              <XRef ID="C2750076" DB="MedGen" />
              <XRef ID="MONDO:0013222" DB="MONDO" />
              <XRef Type="MIM" ID="613319" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39863" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1391" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta Levin type</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+Levin+type/5453" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GNATHODIAPHYSEAL SCLEROSIS</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levin syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with unusual skeletal lesions</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Gnathodiaphyseal dysplasia</ElementValue>
                <XRef ID="MONDO:0008151" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDD</ElementValue>
                <XRef Type="MIM" ID="166260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8698" />
                <XRef ID="8698" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="53697" DB="Orphanet" />
              <XRef ID="C1833736" DB="MedGen" />
              <XRef ID="MONDO:0008151" DB="MONDO" />
              <XRef Type="MIM" ID="166260" DB="OMIM" />
            </Trait>
            <Trait ID="2991" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2L</ElementValue>
                <XRef ID="Muscular+dystrophy%2C+limb-girdle%2C+type+2l/8929" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2L</ElementValue>
                <XRef ID="MONDO:0012652" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608662.0007" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR12</ElementValue>
                <XRef Type="MIM" ID="611307" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12536" />
                <XRef ID="12536" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ANO5 muscle disease is a continuum that ranges from asymptomatic hyperCKemia and exercise-induced myalgia to proximal and/or distal muscle weakness. The most typical presentation is limb-girdle muscular dystrophy type 2L (LGMD2L) with late-onset proximal lower-limb weakness in the fourth or fifth decade (range 15-70 years). Less common is Miyoshi-like disease (Miyoshi muscular dystrophy 3) with early-adult-onset calf distal myopathy (around age 20 years). Incidental hyperCKemia may be present even earlier. Initial symptoms are walking difficulties, reduced sports performance, and difficulties in standing on toes as well as nonspecific exercise myalgia and/or burning sensation in the calf muscles. Muscle weakness and atrophy are frequently asymmetric. Cardiac findings can include cardiomyopathy and arrhythmias and/or left ventricular dysfunction. Bulbar or respiratory symptoms have not been reported. Females have milder disease manifestations than males. Disease progression is slow in both the LGMD and distal forms; ambulation is preserved until very late in the disease course. Life span is normal.</Attribute>
                <XRef ID="NBK114459" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23193613</ID>
                <ID Source="BookShelf">NBK114459</ID>
              </Citation>
              <XRef ID="206549" DB="Orphanet" />
              <XRef ID="C1969785" DB="MedGen" />
              <XRef ID="MONDO:0012652" DB="MONDO" />
              <XRef Type="MIM" ID="611307" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="652327" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="41012_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000338804" DateUpdated="2018-12-15" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="-" referenceAllele="G" start="22291963" stop="22291963" variantLength="1" />
            <GeneLocation>NM_213599.2:Ex18</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD134530" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ANO5</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3001671" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_213599.2:c.2004delG|OMIM:613319" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001526456" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.2004delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613319" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1204182" SubmissionDate="2022-02-23" DateLastUpdated="2023-03-04" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDXSV:221619" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000617770" DateUpdated="2023-03-04" DateCreated="2017-12-19" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Reported as pathogenic in ClinVar (ref; ClinVar SCV000617770; Landrum et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28888072, 23663589)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:744673</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.2004del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_89_20220223054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3967787" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="5164204f03fcbbe25a1ba4885e12099cbb7a297cde852c1c4eb558b0577e405e|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002017225" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-06-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.2004del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1601437" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="3054380|MedGen:C1969785;C1833736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000829553" DateUpdated="2024-02-28" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21186264</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23606453</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25891276</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30919934</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23663589</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu669Phefs*6) in the ANO5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANO5 are known to be pathogenic (PMID: 21186264, 23606453, 25891276, 30919934). This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with ANO5-related muscular dystrophy (PMID: 23663589). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 285669). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.22291961del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969785" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833736" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7901686" SubmissionDate="2023-12-29" DateLastUpdated="2024-01-26" DateCreated="2024-01-26">
        <ClinVarSubmissionID localKey="nvtapin_pin_22095" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004228700" DateUpdated="2024-01-26" DateCreated="2024-01-26" Type="SCV" Version="1" SubmitterName="GenomeConnect - Invitae Patient Insights Network" OrgID="508034" OrganizationCategory="patient registry" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>Variant interpreted as Pathogenic and reported on 04-06-2020 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">60</Age>
              <Age Type="maximum" age_unit="years">69</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Diagnostic</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <Description>Gene Panel Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2020-04-06" integerValue="500031">Invitae</Attribute>
                <Comment>Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <Method>
              <Description>Sanger Sequencing</Description>
              <MethodType>phenotyping only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2021-05-17" Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002960" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001370" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002242" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001513" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0410009" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000826" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000836" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0011438" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.2:c.2004del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969785" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2750076" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14120880</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9757154" SubmissionDate="2024-06-29" DateLastUpdated="2024-07-07" DateCreated="2024-05-07">
        <ClinVarSubmissionID localKey="NM_213599.3:c.2004delG|MedGen:C2931907" />
        <ClinVarAccession Accession="SCV005040504" DateUpdated="2024-07-07" DateCreated="2024-05-07" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23663589</ID>
          </Citation>
          <Comment>Variant summary: ANO5 c.2004delG (p.Leu669PhefsX6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.2e-05 in 251436 control chromosomes. c.2004delG has been reported in the literature in compound heterozygous individuals affected with ANO5 muscular dystrophy (e.g. Liewluck_2013). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 23663589). ClinVar contains an entry for this variant (Variation ID: 285669). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANO5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_213599.3:c.2004delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931907" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>clinvar-submission.2024-03.anno.csv</SubmissionName>
          <SubmissionName>clinvar-submission.2024-03.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011438" MappingRef="HP">
        <MedGen CUI="C4023357" Name="Maternal teratogenic exposure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001513" MappingRef="HP">
        <MedGen CUI="C0028754" Name="Obesity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Disease" MappingType="XRef" MappingValue="C1969785" MappingRef="MedGen">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3967787" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000836" MappingRef="HP">
        <MedGen CUI="C0020550" Name="Hyperthyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3001671" TraitType="Disease" MappingType="XRef" MappingValue="613319" MappingRef="OMIM">
        <MedGen CUI="C2750076" Name="Miyoshi muscular dystrophy 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Disease" MappingType="XRef" MappingValue="C1833736" MappingRef="MedGen">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002242" MappingRef="HP">
        <MedGen CUI="C4316788" Name="Abnormal intestine morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1204182" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1601437" TraitType="Disease" MappingType="XRef" MappingValue="C1833736" MappingRef="MedGen">
        <MedGen CUI="C1833736" Name="Gnathodiaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002960" MappingRef="HP">
        <MedGen CUI="C0004368" Name="Autoimmunity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="652327" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000826" MappingRef="HP">
        <MedGen CUI="C0034013" Name="Precocious puberty" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9757154" TraitType="Disease" MappingType="XRef" MappingValue="C2931907" MappingRef="MedGen">
        <MedGen CUI="C2931907" Name="Autosomal recessive limb-girdle muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1601437" TraitType="Disease" MappingType="XRef" MappingValue="C1969785" MappingRef="MedGen">
        <MedGen CUI="C1969785" Name="Autosomal recessive limb-girdle muscular dystrophy type 2L" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Disease" MappingType="XRef" MappingValue="C2750076" MappingRef="MedGen">
        <MedGen CUI="C2750076" Name="Miyoshi muscular dystrophy 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001370" MappingRef="HP">
        <MedGen CUI="C0003873" Name="Rheumatoid arthritis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7901686" TraitType="Finding" MappingType="XRef" MappingValue="HP:0410009" MappingRef="HP">
        <MedGen CUI="C4073188" Name="Abnormality of the somatic nervous system" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

